• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TWE
Click for more information
2.57% $11.96

TREASURY WINE ESTATES LIMITED - News & Media

Market Cap $9.724B  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Beverages - Wineries & Distilleries

Treasury Wine Estates Limited is an Australia-based wine company. The Company is involved... Treasury Wine Estates Limited is an Australia-based wine company. The Company is involved in the production, marketing and sale of wine. It owns wine production and packaging facilities. In Australia, it owns and operates seven wineries and one packaging facility, with wines primarily produced in South Australia and Victoria. In New Zealand, it owns a winery in Marlborough. In the United States, it has seven wineries and one packaging facility in California’s North and Central Coast regions. In Europe, it owns one winery in Italy and three wineries in France. It has three segments. The Penfolds segment is engaged in the manufacturing, sale and marketing of Penfolds wine globally. Treasury Premium Brands segment is engaged in the manufacturing, sale and marketing of wine within Australia, Asia, Europe, the Middle-East and Africa. Treasury Americas segment is engaged in the manufacture, sale and marketing of wine within the North American and Latin American regions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Treasury Wine Estates to acquire California-based luxury wine brand DAOU Vineyards

Treasury Wine Estates (ASX:TWE) is set to acquire DAOU Vineyards, a highly regarded luxury wine brand based in California.

31 Oct 2023 12:38 (AEDT)

Treasury Wine Estates cheers Australian tariff review for Chinese comeback

Australian global winemaking and distribution business Treasury Wine Estates (ASX:TWE) shares are on the rise this morning.

23 Oct 2023 11:00 (AEDT)



(20min delay)
Last
$11.96 		Change
0.300(2.57%) 		Mkt cap ! $9.724B
Open High Low Value Volume
$11.59 $12.03 $11.59 $21.34M 1.796M

Buyers (Bids)

No. Vol. Price($)
23 7568 $11.96
 

Sellers (Offers)

Price($) Vol. No.
$11.97 2433 16
View Market Depth
Last trade - 14.42pm 02/10/2024 (20 minute delay) ?
Last
$11.99 		  Change
0.300 ( 2.74 %)
Open High Low Volume
$11.60 $12.03 $11.60 473770
Last updated 15.01pm 02/10/2024 ?
TWE (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.